Table 3 The association between empiric therapeutic AC and mortality of patients with COVID-19 based on the D-dimer level
D-Dimer level (ng/mL) | N. of death/N. at risk (%) | Univariate analysis | |||
|---|---|---|---|---|---|
Total | Therapeutic AC | Prophylactic AC | OR (95% CI) | p value | |
≥500 | 150/230 (65.2) | 57/92 (62.0) | 93/138 (67.4) | 0.788 (0.454–1.367) | 0.397 |
≥1000 | 89/134 (66.4) | 39/63 (61.9) | 50/71 (70.4) | 0.683 (0.332–1.402) | 0.297 |
≥2000 | 65/103 (63.1) | 29/49 (59.2) | 36/54 (66.7) | 0.725 (0.325–1.618) | 0.432 |
≥3000 | 52/80 (65.0) | 23/36 (63.9) | 29/44 (65.9) | 0.915 (0.364–2.302) | 0.851 |
≥4000 | 37/59 (62.7) | 16/29 (55.2) | 21/30 (70.0) | 0.527 (0.181–1.538) | 0.239 |
≥5000 | 34/50 (68.0) | 16/26 (61.5) | 18/24 (75.0) | 0.533 (0.158–1.799) | 0.308 |
≥6000 | 30/44 (68.2) | 13/21 (61.9) | 17/23 (73.9) | 0.574 (0.159–2.066) | 0.393 |
≥7000 | 26/39 (66.7) | 11/19 (57.9) | 15/20 (75.0) | 0.458 (0.117–1.789) | 0.257 |